Department of Chemistry of Natural Compounds, University of Chemistry and Technology in Prague, Technická 5, 16028 Prague, Czech Republic.
Isotope Laboratory, Institute of Experimental Botany, Academy of Sciences of the Czech Republic, Vídeňská 1083, 14220 Prague, Czech Republic.
Molecules. 2023 Nov 22;28(23):7718. doi: 10.3390/molecules28237718.
The results of the most recent investigation of triterpenoid-based antiviral agents namely in the HIV-1 and HSV-1 treatment were reviewed and summarized. Several key historical achievements are included to stress consequences and continuity in this research. Most of the agents studied belong to a series of compounds derived from betulin or betulinic acid, and their synthetic derivative is called bevirimat. A termination of clinical trials of bevirimat in Phase IIb initiated a search for more successful compounds partly derived from bevirimat or designed independently of bevirimat structure. Surprisingly, a majority of bevirimat mimics are derivatives of betulinic acid, while other plant triterpenoids, such as ursolic acid, oleanolic acid, glycyrrhetinic acid, or other miscellaneous triterpenoids, are relatively rarely involved in a search for a novel antiviral agent. Therefore, this review article is divided into three parts based on the leading triterpenoid core structure.
对基于三萜类化合物的抗病毒药物(包括 HIV-1 和 HSV-1 治疗)的最新研究结果进行了回顾和总结。其中包括了一些重要的历史成就,以强调该研究的连续性。研究中使用的大多数药物都属于一系列从白桦脂醇或白桦脂酸衍生而来的化合物,它们的合成衍生物称为比立夫定。由于比立夫定在 IIb 期临床试验中被终止,人们开始寻找更有效的化合物,这些化合物部分来源于比立夫定或独立于比立夫定结构设计。令人惊讶的是,大多数比立夫定类似物都是白桦脂酸的衍生物,而其他植物三萜类化合物,如熊果酸、齐墩果酸、甘草次酸或其他杂类三萜类化合物,在寻找新型抗病毒药物的过程中相对较少涉及。因此,本文根据主要的三萜类核心结构分为三部分。